In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 1.8 below Tandem Diabetes Care Inc average.

Within Medical Equipment & Supplies industry 85 other companies have achieved higher Quick Ratio than Tandem Diabetes Care Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 1164, from total ranking in the first quarter 2026 at 2086.

Explain Quick Ratio?
How much Cash & cash equivalents TNDM�s has?
What are TNDM�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TNDM Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	129.92 %	-18.6 %	14.83 %	31.43 %	-31.17 %
Y / Y Cash & cash equivalent Change	44.59 %	54.7 %	-33.23 %	-32.58 %	-30.29 %
Quick Ratio MRQ	1.8	2.86	1.37	1.44	2.87
TNDM's Total Ranking	# 1164	# 2086	# 1879	# 1298	# 1908
Seq. Current Liabilities Change	27.09 %	-6.85 %	-3.45 %	101.16 %	-55 %
Seq. Cash & cash equivalent Change	-20.04 %	94.85 %	-8.29 %	1.19 %	-14.45 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 86
Healthcare Sector	# 519
Overall Market	# 1478

Quick Ratio Statistics
High	Average	Low
42.33	5.88	0.43
(Dec 31 2009)		(Sep 30 2017)

Financial Statements
Tandem Diabetes Care Inc 's Current Liabilities	$ 253 Millions	Visit TNDM's Balance sheet
Tandem Diabetes Care Inc 's Cash & cash equivalent	$ 456 Millions	Visit TNDM's Balance sheet
Source of TNDM's Sales		Visit TNDM's Sales by Geography

Cumulative Tandem Diabetes Care Inc 's Quick Ratio

TNDM's Quick Ratio for the trailling 12 Months

TNDM Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	25.1 %	-1.95 %	25.24 %	36.17 %	49.26 %
Y / Y Cash & cash equivalent TTM Growth	2.66 %	-13.58 %	-29.27 %	-22.56 %	-15.41 %
Quick Ratio TTM	1.85	2.01	1.64	1.89	2.25
Total Ranking TTM	# 2147	# 2931	# 2286	# 2470	# 2553
Seq. Current Liabilities TTM Growth	19.21 %	-5.76 %	3.62 %	7.46 %	-6.57 %
Seq. Cash & cash equivalent TTM Growth	9.39 %	15.56 %	-10.11 %	-9.66 %	-7.91 %

Quick ratio ranking by company, industry and sector >> Back to TNDM Financial Strength Comparisons >> Go to Compare TNDM Quick Ratio to its Competitors

News about Tandem Diabetes Care Inc Quick Ratio

Tandem Diabetes Care Prices Upsized Private Placement of $2750 Million of Convertible Senior Notes Due 2029; Quick Ratio Falls in Q4 2023

Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029; Quick Ratio Falls in Q4 2023
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, has announced the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 in a private placement. This offering was upsized from the previous amount. The notes were offered to qualified institutional buyers under Rule 144A of the Securities Act of 1933.
In the wake of an increase in Current Liabilities in the fourth quarter of 2023, Tandem Diabetes Care s Quick Ratio fell to 3.49, which is still above the company s average Quick Ratio. It is worth noting that seven other companies within the industry have achieved higher Quick Ratios in the same quarter.

On the trailing twelve months basis Due to growth in Current Liabilities in the Q2 2026 to $253.01 millions, cumulative Quick Ratio decreased to 1.85 above the TNDM average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Tandem Diabetes Care Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 2151.

Explain Quick Ratio?
How much Cash & cash equivalents TNDM�s has?
What are TNDM�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 206
Healthcare Sector	# 903
Within the Market	# 1164

trailing twelve months Quick Ratio Statistics
High	Average	Low
5.39	1.59	0.21
(Jun 30 2011)		(Mar 31 2025)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Transmedics Group Inc	4.81	$ 472.675 Millions	$ 98.283 Millions
Aethlon Medical Inc	4.76	$ 4.934 Millions	$ 1.036 Millions
Bluejay Diagnostics Inc	4.53	$ 9.599 Millions	$ 2.117 Millions
Hyperfine Inc	4.51	$ 43.458 Millions	$ 9.629 Millions
Innovative Eyewear Inc	4.36	$ 2.455 Millions	$ 0.563 Millions
Autonomix Medical Inc	4.23	$ 3.460 Millions	$ 0.818 Millions
Sharps Technology Inc	4.16	$ 12.071 Millions	$ 2.903 Millions
Trisalus Life Sciences Inc	4.14	$ 46.288 Millions	$ 11.172 Millions
Kestra Medical Technologies Ltd	4.12	$ 198.911 Millions	$ 48.269 Millions
Sight Sciences Inc	3.89	$ 79.753 Millions	$ 20.499 Millions
Irhythm Holdings Inc	3.82	$ 839.951 Millions	$ 219.981 Millions
Nutriband Inc	3.77	$ 3.422 Millions	$ 0.907 Millions
Logicmark Inc	3.71	$ 6.596 Millions	$ 1.779 Millions
Axogen inc	3.67	$ 111.412 Millions	$ 30.374 Millions
Procept Biorobotics Corporation	3.60	$ 230.952 Millions	$ 64.196 Millions
Heartbeam Inc	3.54	$ 8.700 Millions	$ 2.460 Millions
Mimedx Group Inc	3.53	$ 135.839 Millions	$ 38.498 Millions
Sensus Healthcare Inc	3.51	$ 15.186 Millions	$ 4.327 Millions
Outset Medical Inc	3.35	$ 147.194 Millions	$ 43.891 Millions
Inspiremd Inc	3.15	$ 30.421 Millions	$ 9.646 Millions
Fractyl Health Inc	3.00	$ 47.140 Millions	$ 15.736 Millions
Vivani Medical Inc	2.99	$ 19.894 Millions	$ 6.659 Millions
Retractable Technologies Inc	2.98	$ 39.870 Millions	$ 13.365 Millions
Neuropace Inc	2.97	$ 51.700 Millions	$ 17.433 Millions
Apyx Medical Corp	2.95	$ 27.617 Millions	$ 9.354 Millions
Omada Health Inc	2.94	$ 221.712 Millions	$ 75.483 Millions
Clearpoint Neuro Inc	2.85	$ 29.363 Millions	$ 10.313 Millions
Penumbra Inc	2.82	$ 658.795 Millions	$ 233.776 Millions
Glaukos Corp	2.80	$ 286.594 Millions	$ 102.329 Millions
Pulmonx Corporation	2.76	$ 56.393 Millions	$ 20.405 Millions

Date modified: 2026-09-26T06:58:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.